Allergan cites DTC spending as factor in strong Q2 results

Allergan cited strong spending behind DTC and detailing as factors in reporting stronger-than-expected Q2 results. The firm saw solid gains in its eyecare products, breast implants, medical devices for obesity and Botox for a 23% gain over Q2 2006.

You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical